Martino Picardo

Martino is Chairman of Discovery Park and an Independent Consultant, based in
Manchester. From June 2011- July 2017, Martino was the first CEO of the Stevenage
Bioscience Catalyst an ambitious concept to develop an Incubator and Accelerator,
followed by a world class Science Park for the Life Sciences sector Having been
CEO at Stevenage Bioscience Catalyst, Martino was recently Entrepreneur in
Residence at UMIP, Manchester (2017-2020) and was working part-time with the
NHS in Manchester, also as an Entrepreneur in Residence.

Martino has a PhD in Biochemistry from Cardiff University and spent 4 years at
Baylor College of Medicine, Houston, TX in Cardiovascular research. Martino joined
Amersham International in 1991 and subsequently went on to manage the R&D
Technology Transfer Group, based in Cardiff and developing high throughput
screening technologies for the Pharmaceutical sector.

Following the merger of Amersham with Pharmacia Biotech, Martino became the
Science Director for the Cardiff site, Martino then became a Business Manager for
Manchester Biotech Ltd. and subsequently Manchester Innovation Ltd. in June 1999.
When the Universities of Manchester and UMIST merged, he became Managing
Director of UMIC and MICL and was also a Board member of UKBI (UK Business
Incubation).

Martino has also been a Board member of the Hertfordshire LEP. Most recently,
Martino was appointed to the Board of BIONOW, the Northern member Organization
for Life Sciences, as a non- Executive Director (2018-2023). He is currently
Chairman of Discovery Park Ltd., Vitarka Therapeutics Ltd and Evidential Ltd. He is
also a Director of Discovery Park Ventures.